Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014.
“Investor Michael Burry disclosed on Monday that his hedge fund, Scion Asset Management, has taken positions against tech heavyweights Nvidia (NVDA) and Palantir (PLTR).”
Source: Yahoo Finance.